Asensus Surgical, Inc.
ASXC
ASXC was delisted on the 21st of August, 2024.
68 hedge funds and large institutions have $6.88M invested in Asensus Surgical, Inc. in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 17 closing their positions.
155% more call options, than puts
Call options by funds: $158K | Put options by funds: $62K
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
15% less funds holding
Funds holding: 80 → 68 (-12)
49% less capital invested
Capital invested by funds: $13.5M → $6.88M (-$6.59M)
71% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$63.2K |
| 2 |
JP Morgan Chase
New York
|
+$53.7K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$39.7K |
| 4 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
+$36.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$29.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$246K |
| 2 |
Millennium Management
New York
|
-$176K |
| 3 |
BlackRock
New York
|
-$84.6K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$78.3K |
| 5 |
Two Sigma Investments
New York
|
-$55.8K |
ASXC Hedge Fund Activity: Q3 2023 in Review
68 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q3 2023, worth a combined $6.88M — down 49% from $13.5M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ASXC and 5 opened new positions — a net loss of 12 holders — while 12 trimmed existing stakes and 16 added.
The largest buyer was Geode Capital Management, adding an estimated $63.2K. The largest seller was GSA Capital Partners, cutting an estimated $246K.
- 68 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q3 2023, down from 80 in Q2 2023.
- Funds reported $6.88M of Asensus Surgical, Inc. stock for Q3 2023, down 49% quarter-over-quarter.
- 5 funds opened new Asensus Surgical, Inc. positions in Q3 2023 and 17 closed out, a net change of -12 holders.
- The largest Asensus Surgical, Inc. buyer in Q3 2023 was Geode Capital Management, an estimated $63.2K added.
- The largest Asensus Surgical, Inc. seller in Q3 2023 was GSA Capital Partners, an estimated $246K sold.
Based on aggregated 13F filings for Q3 2023.